]>
IRCT2015050119396N3 IRCT 2016-01-31 Hormozgan University of Medical Sciences Estimating the therapeutic effect of 17 alpha-hydroxy progesterone caproate in preventing preterm labor after inhibiting uterine contractions Estimating the therapeutic effect of 17 alpha-hydroxy progesterone caproate in preventing preterm labor after inhibiting uterine contractions 2014-07-30 anticipated 200 Complete https://irct.ir/trial/17343 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Other design features: This study will be randomly sampling. N/A Preterm labour. Intervention 1: The treatment group received a weekly intramuscular injection of 17 alpha-hydroxyl progesterone (500 mg). They were advised to continue it until their 36th week of pregnancy at home. Within 48 hours of hospitalization (prior to their discharge) the patient was once again examined by the researcher. This drug made by pharmaceutical company bayer of schering pharma. Intervention 2: The control group would receive no such injection. Within 48 hours of hospitalization (prior to their discharge) the patient was once again examined by the researcher.
public Azin Alavi
Shariati Hospital, St. shahid Nasr- Bandar Abbas
Bandar Abbas Iran (Islamic Republic of) +98 76 3333 2424 azin_alavi@yahoo.com Shariati Hospital scientific Azin Alavi
Shariati hospital, Hormozgan University of Medical Sciences
Bandar Abbas Iran (Islamic Republic of) +98 76 3333 2424 azin_alavi@yahoo.com Shariati hospital, Hormozgan University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: Between 26-34 weeks pregnancy age; There premature uterine contractions. Exclusion criteria: the pregnancy age above 34 weeks (since in this group there would be no reason for preventing uterine contractions due to the fetal lung maturation); preterm rupture of membranes; corioamnionite, blood loss prior to the labor due to placental abruption or previa;multiple pregnancies; concomitant systemic diseases (preeclampsia, gestational diabetes (GDM); cardiovascular diseases; kidney diseases; asthma; hyperthyroid; …). 20 years 40 years Female O60.1 Preterm labour without delivery Treatment - Drugs N/A The treatment group received a weekly intramuscular injection of 17 alpha-hydroxyl progesterone (500 mg). They were advised to continue it until their 36th week of pregnancy at home. Within 48 hours of hospitalization (prior to their discharge) the patient was once again examined by the researcher. This drug made by pharmaceutical company bayer of schering pharma. The control group would receive no such injection. Within 48 hours of hospitalization (prior to their discharge) the patient was once again examined by the researcher. The prevention of preterm birth after inhibition of uterine contractions. Timepoint: 48 hours after the intervention. Method of measurement: Check up and examination. Hormozgan University of Medical Sciences Approved 2013-07-22 Ethics committee of Hormozgan University of Medical Sciences vice chancellor for research and technology, Shahid Mohamadi Hospital Bandar Abbas Iran (Islamic Republic of)